11.01.2013 Views

5th EuropEan MolEcular IMagIng MEEtIng - ESMI

5th EuropEan MolEcular IMagIng MEEtIng - ESMI

5th EuropEan MolEcular IMagIng MEEtIng - ESMI

SHOW MORE
SHOW LESS

Create successful ePaper yourself

Turn your PDF publications into a flip-book with our unique Google optimized e-Paper software.

8<br />

WarSaW, poland May 26 – 29, 2010<br />

Welcome to the 5 th EMIM in Warsaw, Poland<br />

Dear Colleagues,<br />

on behalf of the <strong>ESMI</strong> as well as the other organising and contributing societies and networks it is our great pleasure<br />

to welcome you to Warsaw, Poland, for the 5 th European Molecular Imaging Meeting. EMIM 2010 brings together top<br />

European scientists from 3 societies, 2 European Networks of Excellence (NoEs) and 2 COST actions. With great honour<br />

we may state that your fellow attendees represent not only colleagues from all over Europe, but also Asia and the US.<br />

The societies and networks with primary responsibility for organising the meeting are:<br />

• European Society for Molecular Imaging – <strong>ESMI</strong><br />

• NoE Diagnostic Molecular Imaging – DiMI<br />

• European Cooperation in Science and Technology – COST Actions D38 and BM0607<br />

• European Society of Radiology – ESR<br />

• We also gratefully acknowledge the contribution from the following participating organisations:<br />

• European Association of Nuclear Medicine – EANM<br />

• NoE Clinical Gene Transfer and Therapy – Clinigene<br />

All these organisations were working together, with input from a scientifically complementary scientific steering committee,<br />

to develop a strong scientific programme which integrates developments in imaging technologies and molecular<br />

imaging agents with applications for drug development, basic science investigations, and clinical translation with special<br />

emphasis in the main disease burdens of our society such as cancer, cardiovascular disease and neurodegeneration.<br />

We developed the 5 th EMIM scientific programme primarily on the outstanding strength of submitted abstracts.<br />

About 150 abstracts were submitted, reviewed and scored. Then, each of the concurrent session co-chairs reviewed<br />

the scored abstracts which were considered relevant to their particular sessions. Session co-chairs selected abstracts<br />

for oral presentation based on average abstract score, session content and structure. Attention was also paid to diversity<br />

of disciplines and geographical distribution. From this effort 39 abstracts were integrated into the Parallel as<br />

well as Plenary Sessions that bring attendees from different disciplines together for a comprehensive examination of<br />

the role of molecular imaging in particular biomedical problems. 21 of these oral abstract presentations will be held<br />

by Young Investigator Award (YIA) applicants. The YIA selection committee is going to select the best 3 YIA presentations<br />

to be held again during the final Plenary Session on Saturday where then THE Young Investigator Awardee<br />

will be announced. Furthermore, special attention has been put on seven guided poster walks which have been<br />

scheduled on Thursday and Friday afternoon with no other competing sessions in order to enhance the knowledge<br />

exchange of experienced and young researchers. Each of the guided poster walks will be chaired by two chairs and will<br />

result in one poster award. The seven Poster Awards will also be offered during the Closing Ceremony on Saturday.<br />

We are especially proud and thankful that Prof. Dr. Christopher Contag will give the inaugural lecture,<br />

entitled, “Point-of-care microscopy: molecular imaging with cellular resolution”. In addition, we have planned 5 exciting<br />

plenary lectures, covering topics on probe design, systems biology, cancer, neuroinflammation, and atherosclerosis.<br />

Furthermore, we have dedicated one Plenary Session each to Excellent, Late Breaking, and YIA Abstracts as<br />

well as to Current Contribution of Imaging Technologies to Drug Development.<br />

We would like to take this opportunity to acknowledge the support of this year’s sponsors of the conference, especially<br />

recognizing the continued interest and support from DG Research of the European Commission. Moreover<br />

we would like to thank YOU for participating in this year’s EMIM and making it possible by your attendance. We<br />

hope you will enjoy the conference. If this is not your first time attending an EMIM conference then welcome back<br />

and we hope you will establish new contacts and continue to expand your network of scientific excellence. Please<br />

help first-time attendees to meet others and generally make people feel at home. Regardless whether this is your<br />

first time with us or not we will endeavour to have you come back again in the future.<br />

As in previous years our intention is that this high-level meeting will foster the coherence of a sustainable European<br />

Molecular Imaging Community with the common goal to translate fundamental research discoveries into medical<br />

application and health benefit for the European Society.<br />

Sincerely,<br />

The <strong>5th</strong> Andreas H. Jacobs, <strong>ESMI</strong> President<br />

Renata Mikołajczak, Local Organiser<br />

Clemens W.G.M. Löwik, <strong>ESMI</strong> Vice President<br />

Bertrand Tavitian, <strong>ESMI</strong> Past President<br />

Silvio Aime, <strong>ESMI</strong> Secretary<br />

European Molecular Imaging Meeting Executive Committee<br />

Simone Mergui, <strong>ESMI</strong> Treasurer<br />

imaging life

Hooray! Your file is uploaded and ready to be published.

Saved successfully!

Ooh no, something went wrong!